Swiss National Bank Boosts Stock Position in Change Healthcare Inc. (NASDAQ:CHNG)
Swiss National Bank Boosts Stock Position in Change Healthcare Inc. (NASDAQ:CHNG)
Swiss National Bank raised its position in shares of Change Healthcare Inc. (NASDAQ:CHNG – Get Rating) by 7.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 552,451 shares of the company's stock after purchasing an additional 39,700 shares during the quarter. Swiss National Bank owned 0.18% of Change Healthcare worth $12,043,000 at the end of the most recent reporting period.
Change Healthcare Inc.(納斯達克代碼：Chng-Get Rating)在最近一次提交給美國證券交易委員會的13F文件中稱，瑞士央行第一季度將其在該公司股票的持倉量上調了7.7%。該基金在本季度額外購買了39,700股後，持有552,451股該公司股票。在最近一個報告期結束時，瑞士國家銀行擁有Change Healthcare 0.18%的股份，價值12,043,000美元。
A number of other hedge funds have also recently modified their holdings of CHNG. C M Bidwell & Associates Ltd. purchased a new stake in shares of Change Healthcare in the first quarter worth about $90,000. FNY Investment Advisers LLC boosted its stake in shares of Change Healthcare by 5,400.0% in the first quarter. FNY Investment Advisers LLC now owns 5,500 shares of the company's stock worth $119,000 after buying an additional 5,400 shares during the last quarter. Advisor Group Holdings Inc. boosted its stake in shares of Change Healthcare by 13.0% in the fourth quarter. Advisor Group Holdings Inc. now owns 6,335 shares of the company's stock worth $135,000 after buying an additional 731 shares during the last quarter. Fieldpoint Private Securities LLC boosted its stake in shares of Change Healthcare by 27.8% in the first quarter. Fieldpoint Private Securities LLC now owns 6,579 shares of the company's stock worth $143,000 after buying an additional 1,433 shares during the last quarter. Finally, Comerica Bank boosted its stake in shares of Change Healthcare by 40.0% in the first quarter. Comerica Bank now owns 14,658 shares of the company's stock worth $346,000 after buying an additional 4,188 shares during the last quarter. Hedge funds and other institutional investors own 96.09% of the company's stock.
其他一些對衝基金最近也調整了對Chng的持股。C M Bidwell&Associates Ltd.在第一季度購買了Change Healthcare價值約90,000美元的新股。FNY Investment Advisers LLC在第一季度將其在Change Healthcare的股份增加了5,400.0%。FNY Investment Advisers LLC現在持有該公司5,500股股票，價值11.9萬美元，在上個季度又購買了5,400股。Advisor Group Holdings Inc.在第四季度增持了Change Healthcare股票13.0%。Advisor Group Holdings Inc.現在持有該公司6,335股股票，價值135,000美元，上個季度又購買了731股。FieldPoint Private Securities LLC在第一季度將其在Change Healthcare的持股增加了27.8%。FieldPoint Private Securities LLC現在持有該公司6,579股股票，價值143,000美元，上個季度又購買了1,433股。最後，Comerica Bank在第一季度增持了Change Healthcare股票40.0%。Comerica Bank現在持有14,658股該公司股票，價值34.6萬美元，上個季度又購買了4,188股。對衝基金和其他機構投資者持有該公司96.09%的股票。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
A number of analysts have recently commented on the company. Piper Sandler restated a "buy" rating and issued a $26.00 target price on shares of Change Healthcare in a research note on Tuesday, April 26th. William Blair reaffirmed a "market perform" rating on shares of Change Healthcare in a report on Friday, June 3rd. Cowen set a $27.75 price target on Change Healthcare in a report on Monday, June 20th. Credit Suisse Group upped their price target on Change Healthcare from $25.75 to $27.75 and gave the stock a "neutral" rating in a report on Tuesday, May 31st. Finally, SVB Leerink reaffirmed an "outperform" rating on shares of Change Healthcare in a report on Thursday, May 26th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, Change Healthcare has an average rating of "Moderate Buy" and an average price target of $27.00.
一些分析師最近對該公司發表了評論。派珀·桑德勒在4月26日(星期二)的一份研究報告中重申了對Change Healthcare的“買入”評級，併為其股票設定了26.00美元的目標價。威廉·布萊爾在6月3日星期五的一份報告中重申了對Change Healthcare股票的“市場表現”評級。考恩在6月20日星期一的一份報告中為Change Healthcare設定了27.75美元的目標價。瑞士信貸集團將其對Change Healthcare的目標價從25.75美元上調至27.75美元，並在5月31日週二的一份報告中給予該股“中性”評級。最後，SVB Leerink在5月26日(星期四)的一份報告中重申了對Change Healthcare股票的“跑贏大盤”評級。兩名研究分析師對該股的評級為持有，四名分析師對該股的評級為買入。根據MarketBeat的數據，Change Healthcare的平均評級為“中等買入”，平均目標價為27.00美元。
Change Healthcare Price Performance
改變醫療價格表現
Change Healthcare (NASDAQ:CHNG – Get Rating) last announced its earnings results on Wednesday, May 25th. The company reported $0.34 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.03). Change Healthcare had a negative net margin of 2.20% and a positive return on equity of 12.02%. The firm had revenue of $920.13 million for the quarter, compared to analyst estimates of $902.86 million. During the same period in the previous year, the company earned $0.36 EPS. Change Healthcare's revenue was up 7.6% compared to the same quarter last year. As a group, analysts predict that Change Healthcare Inc. will post 1.3 EPS for the current fiscal year.
Change Healthcare(納斯達克：Chng-Get Rating)最近一次公佈財報是在5月25日星期三。該公司公佈本季度每股收益為0.34美元，低於分析師普遍預期的0.37美元(0.03美元)。Change Healthcare的淨利潤率為負2.20%，股本回報率為正12.02%。該公司本季度營收為9.2013億美元，而分析師預期為9.0286億美元。去年同期，該公司每股收益為0.36美元。與去年同期相比，Change Healthcare的收入增長了7.6%。分析師預計，作為一個整體，Change Healthcare Inc.將公佈本財年每股收益1.3%。
Change Healthcare Profile
更改醫療保健配置文件
(Get Rating)
(獲取評級)
Change Healthcare Inc, an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services.
Change Healthcare Inc.是一家獨立的醫療技術公司，提供數據和分析驅動的解決方案，以增強美國醫療系統的臨牀、財務、行政和患者參與成果。它通過三個部門運作：軟件和分析、網絡解決方案和技術支持的服務。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Change Healthcare (CHNG)
- Which Semiconductor Stocks Are Ready For Big Price Moves?
- Miners Advance On Earnings Despite Broader Economic Challenges
- Lowe's Stands Out Amid Q2 Retail Reports
- Agilent Technologies Proves Its Worth VS Illumina
- Target's Results Cap Upside Potential For Retail Stocks
- 免費獲取StockNews.com關於Change Healthcare(CHNG)的研究報告
- 哪些半導體類股準備好迎接價格大幅波動？
- 儘管面臨更廣泛的經濟挑戰，礦商的收益仍在上漲
- Lowe‘s在第二季度零售報告中脱穎而出
- 安捷倫科技對Illumina證明瞭自己的價值
- 塔吉特的業績上限零售類股的上行潛力
Receive News & Ratings for Change Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Change Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
接受《改變醫療保健日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收最新新聞和分析師對Change Healthcare及相關公司的評級的每日摘要。
譯文內容由第三人軟體翻譯。